Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Receivables: 2010-2025

Historic Change in Receivables for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $29.9 million.

  • Prestige Consumer Healthcare's Change in Receivables rose 439.15% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 865.56%. This contributed to the annual value of $16.3 million for FY2025, which is 158.26% up from last year.
  • Prestige Consumer Healthcare's Change in Receivables amounted to $29.9 million in Q3 2025, which was up 209.44% from -$27.3 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Change in Receivables high stood at $29.9 million for Q3 2025, and its period low was -$27.3 million during Q2 2025.
  • Over the past 3 years, Prestige Consumer Healthcare's median Change in Receivables value was $1.2 million (recorded in 2023), while the average stood at $3.0 million.
  • In the last 5 years, Prestige Consumer Healthcare's Change in Receivables plummeted by 824.98% in 2024 and then spiked by 3,726.04% in 2025.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Change in Receivables stood at -$12.5 million in 2021, then skyrocketed by 170.56% to $8.8 million in 2022, then rose by 29.88% to $11.4 million in 2023, then tumbled by 44.74% to $6.3 million in 2024, then spiked by 439.15% to $29.9 million in 2025.
  • Its Change in Receivables was $29.9 million in Q3 2025, compared to -$27.3 million in Q2 2025 and $25.2 million in Q1 2025.